Loading company
Loading
Latest annual · FY2025
Millions- Free cash flow
- (9)
Latest quarter · Q2 FY2025
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (3)
- Net income
- (3)
CollPlant Biotechnologies Ltd (CLGN) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.4 million | $515,000 | +360.4% | 20-F 2026-03-26 · proof |
| Gross profit | $1.5 million | -$1.1 million | 20-F 2026-03-26 · proof | |
| Operating income | -$11.5 million | -$17.3 million | 20-F 2026-03-26 · proof | |
| Net income | -$11.5 million | -$16.6 million | 20-F 2026-03-26 · proof | |
| Cash from operating activities | -$9.4 million | -$14.1 million | 20-F 2026-03-26 · proof | |
| Free cash flow | -$9.4 million | -$14.6 million | 20-F 2026-03-26 · proof |
- What was CollPlant Biotechnologies Ltd (CLGN)'s revenue in fiscal 2025?
- CollPlant Biotechnologies Ltd (CLGN) reported revenue of $2.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $515,000 the year before (+360.4%). Source: the 20-F filed with the SEC on Mar 26, 2026. SEC
- What was CollPlant Biotechnologies Ltd (CLGN)'s gross profit in fiscal 2025?
- CollPlant Biotechnologies Ltd (CLGN) reported gross profit of $1.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.1 million the year before. Source: the 20-F filed with the SEC on Mar 26, 2026. SEC
- What was CollPlant Biotechnologies Ltd (CLGN)'s operating income in fiscal 2025?
- CollPlant Biotechnologies Ltd (CLGN) reported operating income of -$11.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$17.3 million the year before. Source: the 20-F filed with the SEC on Mar 26, 2026. SEC
- What was CollPlant Biotechnologies Ltd (CLGN)'s net income in fiscal 2025?
- CollPlant Biotechnologies Ltd (CLGN) reported net income of -$11.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$16.6 million the year before. Source: the 20-F filed with the SEC on Mar 26, 2026. SEC
- What was CollPlant Biotechnologies Ltd (CLGN)'s cash from operating activities in fiscal 2025?
- CollPlant Biotechnologies Ltd (CLGN) reported cash from operating activities of -$9.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$14.1 million the year before. Source: the 20-F filed with the SEC on Mar 26, 2026. SEC
- What was CollPlant Biotechnologies Ltd (CLGN)'s free cash flow in fiscal 2025?
- CollPlant Biotechnologies Ltd (CLGN) reported free cash flow of -$9.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$14.6 million the year before. Source: the 20-F filed with the SEC on Mar 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CLGN&period_type=annual&limit=5"Information only, not investment advice.